Literature DB >> 26520656

Comprehensive assessment of prognosis after laparoscopic portoenterostomy for biliary atresia.

Hiroki Nakamura1, Hiroyuki Koga1, Joel Cazares2, Tadaharu Okazaki1, Geoffrey J Lane1, Go Miyano1, Manabu Okawada1, Takashi Doi1, Masahiko Urao1, Atsuyuki Yamataka3,4.   

Abstract

PURPOSE: Total bilirubin (T-bil) is used universally for monitoring post-portoenterostomy (PE) biliary atresia (BA) patients although other biochemical markers [BM; AST/ALT and platelet count (PC)] are also prognostic. We compared open PE (OPE) with laparoscopic PE (LPE) using T-bil, AST/ALT, and PC (3BM) as more comprehensive indicators of postoperative clinical status.
METHODS: Subjects were 31 PE cases (LPE: n = 17; OPE: n = 14). BA classification was type III (n = 16), type II (n = 1) in LPE and type III (n = 12), type I (n = 1), type II (n = 1) in OPE.
RESULTS: Mean ages and weights at PE were similar: 65.5 days, 4.4 kg (LPE) versus 69.3 days, 4.1 kg (OPE); and mean follow-up was 2.5 years for both LPE and OPE. Jaundice clearance (T-bil ≤1.2 mg/dL) was achieved in 16/17 (94.1 %) after LPE versus 10/14 (71.4 %) after OPE (p = NS), but 3BM were closer to normal after OPE. At the time of review, 13/17 LPE cases (76.5 %) were alive with native livers and 4/17 had received LTx (23.5 %) and 10/14 OPE cases (71.4 %) were alive with native livers and 4/14 had received LTx (28.6 %).
CONCLUSIONS: Although JC was better after LPE, 3BM were better after OPE. Further follow-up will prove the comprehensive prognostic value of 3BM.

Entities:  

Keywords:  Biliary atresia; Biochemistry; Laparoscopy; Liver function

Mesh:

Substances:

Year:  2015        PMID: 26520656     DOI: 10.1007/s00383-015-3820-y

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  17 in total

1.  Innovative modification of the hepatic portoenterostomy. Our experience of treating biliary atresia.

Authors:  Hiroyuki Kobayashi; Atsuyuki Yamataka; Masahiko Urao; Tadaharu Okazaki; Toshihiro Yanai; Hiroyuki Koga; Geoffrey J Lane; Takeshi Miyano
Journal:  J Pediatr Surg       Date:  2006-05       Impact factor: 2.545

2.  Validation and reduction of the oxidative stress following laparoscopic operations: a prospective randomized controlled study.

Authors:  Amitai Bickel; Assi Drobot; Michael Aviram; Arie Eitan
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

3.  Experience of treating biliary atresia with three types of portoenterostomy at a single institution: extended, modified Kasai, and laparoscopic modified Kasai.

Authors:  Momoko Wada; Hiroki Nakamura; Hiroyuki Koga; Go Miyano; Geoffrey J Lane; Tadaharu Okazaki; Masahiko Urao; Hiroshi Murakami; Mureo Kasahara; Seisuke Sakamoto; Yoichi Ishizaki; Seiji Kawasaki; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2014-07-27       Impact factor: 1.827

4.  Laparoscopic surgery for biliary atresia and choledochal cyst.

Authors:  Atsuyuki Yamataka; Geoffrey J Lane; Joel Cazares
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

5.  Reappraising the portoenterostomy procedure according to sound physiologic/anatomic principles enhances postoperative jaundice clearance in biliary atresia.

Authors:  Hiroki Nakamura; Hiroyuki Koga; Momoko Wada; Go Miyano; Rafael Dizon; Yoshifumi Kato; Geoffrey J Lane; Tadaharu Okazaki; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2012-02       Impact factor: 1.827

6.  Long-term outcome of adult-to-adult living donor liver transplantation for post-Kasai biliary atresia.

Authors:  Y Uchida; M Kasahara; H Egawa; Y Takada; K Ogawa; Y Ogura; K Uryuhara; D Morioka; S Sakamoto; Y Inomata; Y Kamiyama; K Tanaka
Journal:  Am J Transplant       Date:  2006-08-01       Impact factor: 8.086

7.  Increased susceptibility to liver damage from pneumoperitoneum in a murine model of biliary atresia.

Authors:  Pablo Laje; Fred H Clark; Joshua R Friedman; Alan W Flake
Journal:  J Pediatr Surg       Date:  2010-09       Impact factor: 2.545

8.  Laparoscopic Kasai portoenterostomy for biliary atresia.

Authors:  Edward Esteves; Eriberto Clemente Neto; Miguel Ottaiano Neto; José Devanir; Ruy Esteves Pereira
Journal:  Pediatr Surg Int       Date:  2002-10-08       Impact factor: 1.827

9.  Survival with the native liver after laparoscopic versus conventional kasai portoenterostomy in infants with biliary atresia: a prospective trial.

Authors:  Benno M Ure; Joachim F Kuebler; Nagoud Schukfeh; Carsten Engelmann; Jens Dingemann; Claus Petersen
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

Review 10.  Biliary atresia.

Authors:  Jane L Hartley; Mark Davenport; Deirdre A Kelly
Journal:  Lancet       Date:  2009-11-14       Impact factor: 79.321

View more
  4 in total

Review 1.  Laparoscopic portoenterostomy for biliary atresia: single-center experience and review of literatures.

Authors:  Joel Cazares; Hiroyuki Koga; Hiroshi Murakami; Hiroki Nakamura; Geoffrey Lane; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2017-10-11       Impact factor: 1.827

2.  Comparison of laparoscopic portoenterostomy and open portoenterostomy for the treatment of biliary atresia.

Authors:  Yanan Li; Jinran Gan; Chuan Wang; Zhicheng Xu; Yiyang Zhao; Yi Ji
Journal:  Surg Endosc       Date:  2019-06-12       Impact factor: 4.584

Review 3.  Laparoscopic vs open portoenterostomy in biliary atresia: a systematic review and meta-analysis.

Authors:  David Eugenio Hinojosa-Gonzalez; Luis C Bueno; Andres Roblesgil-Medrano; Gustavo Salgado-Garza; Sofia Hurtado-Arellano; Juan S Farias; Mauricio Torres-Martinez; Jaime A Escarcega-Bordagaray; Marcelo Salan-Gomez; Eduardo Flores-Villalba
Journal:  Pediatr Surg Int       Date:  2021-07-16       Impact factor: 1.827

4.  Bowel perforation after liver transplantation for biliary atresia: a retrospective study of care in the transition from children to adulthood.

Authors:  Yusuke Yanagi; Toshiharu Matsuura; Makoto Hayashida; Yoshiaki Takahashi; Koichiro Yoshimaru; Genshirou Esumi; Tomoaki Taguchi
Journal:  Pediatr Surg Int       Date:  2016-11-23       Impact factor: 1.827

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.